acetylcysteine has been researched along with Thyroid Neoplasms in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Aggarwal, A; Barletta, JA; Lorch, JH; Nehs, MA; Yuan, Z | 1 |
Kang, DY; Kim, SH; Kim, TH; Park, KJ; Park, MK; Suh, H; Yoo, YH | 1 |
Eggo, MC | 1 |
Adler, G; Böhm, BO; Dralle, H; Hoang-Vu, C; Kessler, H; Ludwig, L; Schmid, RM; Wagner, M | 1 |
1 review(s) available for acetylcysteine and Thyroid Neoplasms
Article | Year |
---|---|
Molecular regulation of thyroid gland function.
Topics: Acetylcysteine; Animals; Erythromycin; Humans; Insulin; Insulin-Like Growth Factor I; Integrins; Iodides; Mice; Mitogen-Activated Protein Kinases; Peptide Hydrolases; Phosphatidylinositol 3-Kinase; Plasminogen Activators; Rats; Signal Transduction; Thyroid Gland; Thyroid Neoplasms; Vascular Endothelial Growth Factor A | 2010 |
4 other study(ies) available for acetylcysteine and Thyroid Neoplasms
Article | Year |
---|---|
Ketogenic diet combined with antioxidant N-acetylcysteine inhibits tumor growth in a mouse model of anaplastic thyroid cancer.
Topics: Acetylcysteine; Administration, Oral; Animals; Cell Line, Tumor; Diet, Ketogenic; Female; Free Radical Scavengers; Glucose; Humans; Mice; Oxidative Stress; Reactive Oxygen Species; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Xenograft Model Antitumor Assays | 2020 |
Discussion.
Topics: Acetylcysteine; Animals; Antioxidants; Diet, Ketogenic; Mice; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms | 2020 |
Efficacy on anaplastic thyroid carcinoma of valproic acid alone or in combination with doxorubicin, a synthetic chenodeoxycholic acid derivative, or lactacystin.
Topics: Acetylcysteine; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma; Cell Survival; Chenodeoxycholic Acid; Dose-Response Relationship, Drug; Doxorubicin; Drug Evaluation, Preclinical; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Mitochondria; Thyroid Neoplasms; Treatment Outcome; Tumor Cells, Cultured; Valproic Acid | 2009 |
Nuclear factor-kappaB is constitutively active in C-cell carcinoma and required for RET-induced transformation.
Topics: 3T3 Cells; Acetylcysteine; Animals; Apoptosis; Carcinoma, Medullary; Cell Nucleus; Cell Transformation, Neoplastic; Dimerization; DNA-Binding Proteins; DNA, Neoplasm; Drosophila Proteins; Fibroblasts; Humans; I-kappa B Kinase; I-kappa B Proteins; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinases; NF-kappa B; NF-KappaB Inhibitor alpha; Protein Serine-Threonine Kinases; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; ras Proteins; Receptor Protein-Tyrosine Kinases; Signal Transduction; Thyroid Neoplasms; Transcription Factor RelA; Transcription, Genetic; Tumor Cells, Cultured | 2001 |